Boulder, Colorado, United States:
a leading global provider of healthcare products and recognized
innovator in patient monitoring and respiratory care devices, today
launched the Capnostream 20p bedside monitor. The new
capnography solution, with Covidien’s Microstreamή
technology, offers enhanced features that will help clinicians identify
and address serious health threats sooner.
For nearly two decades, clinicians have relied on Microstream
capnography monitoring for an integrated, complete picture of
oxygenation and ventilation. These factors can help clinicians
appropriately manage sedation levels and ensure safe administration of
opioids for pain management. The Capnostream 20p bedside monitor
features the Apnea-Sat Alert™ algorithm, which measures and reports
recurring apnea (temporary cessation of breathing for more than 10
seconds) and oxygen desaturation events.
Frequent apneic events can provide clinicians early warning of
cardiopulmonary complications. Coupling the new Apnea-Sat Alert feature
with trusted capnography technology from Covidien may facilitate early
detection and treatment of cardiac arrest and others serious conditions.
“Studies show that as many as 88% of hospitalized patients may be at
risk for recurrent apneas, yet we’re only identifying and treating a
very small number,*” said Scott Kelley, M.D., Chief Medical Officer,
Respiratory and Monitoring Solutions, Covidien. “The Capnostream 20p
bedside monitor will help increase apnea detection rates and represents
an important advancement in continuous patient monitoring that we
believe will help save lives.”
The Apnea-Sat Alert feature detects apneas per hour and oxygen
desaturation fluctuations, displaying the values on the Capnostream 20p
monitor screen without requiring additional equipment or clinical
Apnea-Sat Alert technology is a part of the broader family of Smart
Alarm Management™ integrated algorithms that help mitigate alarm fatigue
while meeting Joint Commission guidelines for alarm management. These
Smart Breath Detection™
, a proprietary filter and pattern
recognition algorithm that screens out low-amplitude “non-breath” etCO2
excursions like snoring, talking or crying, to provide a more accurate
Smart Alarm for Respiratory Analysis (SARA™)
, alarm management
technology that helps prevent alarm fatigue by reducing clinically
insignificant respiratory alarms.
technology that helps analyze oxygen
Integrated Pulmonary IndexTM (IPI)
algorithm that combines four respiratory measurements–capnography,
respiratory rate, pulse rate and pulse oximetry–to provide clinicians
with an integrated snapshot of respiratory status.
The Capnostream 20p bedside monitor is further differentiated by the
Microstream-enabled microMediCO2™ module
measurement bench. The module offers easy integration into host monitor
configurations and is designed to support future Smart Capnography
algorithms without requiring hardware upgrades.
The Capnostream 20p bedside monitor can be used across all care settings
and complies with ISO alarm standards. For more information about the
device, visit www.covidien.com/rms/pages.aspx?page=Product/Capnostream-20p-Bedside-Patient-Monitor.
Covidien is a leading global healthcare products company that creates
innovative medical solutions for better patient outcomes and delivers
value through clinical leadership and excellence. Covidien manufactures,
distributes and services a diverse range of industry-leading products in
medical devices and supplies. With 2012 revenue of $9.9 billion,
Covidien has 38,000 employees worldwide in 70 countries, and its
products are sold in over 140 countries. Please visit www.covidien.com
to learn more about our business.
Kumar S, McElligott D, Goyal A, Baugh M, Ionita RN. Risk of
obstructive sleep apnea (OSA) in hospitalized patients.
Frey WC, Pilcher J: Obstructive sleep-related breathing disorders in
patients evaluated for bariatric surgery. Obes Surg. 2003; 13:676-683.
Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The
occurrence of sleep-disordered breathing among middle-aged adults. N
Engl J Med. 1993;29;328(17):1230-1235.
Rhonda Luniak, 303-406-8743
Coleman Lannum, CFA, 508-452-4343
Lisa Clemence, 508-452-4375
Todd Carpenter, 508-452-4363